Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Pranlukast and mirabegron may work as new diabetes drugs.

Testosterone significantly affects urination differences between male and female mice.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Anti-glycation treatments might slow skin aging, but more research is needed.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Polymeric nanoparticles show promise for treating skin diseases.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The Rotterdam Study aims to understand various diseases in older adults.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Oxidative stress contributes to hair graying and loss as we age.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Minoxidil boosts hair growth by activating PGHS-1.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.